Metabolome sequencing reveals that PRMT1 promotes the progression of invasive micropapillary carcinoma of the breast and predicts a poor prognosis

This study identified the metabolic type-related features and intermediate transition morphology of IMPC, and the identification of potential targets of PRMT1 is expected to provide a basis for the precise diagnosis and treatment of breast IMPC.PMID:37301537 | DOI:10.1016/j.ajpath.2023.05.010
Source: Am J Pathol - Category: Pathology Authors: Source Type: research